NCT02796105View on ClinicalTrials.gov

Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors

PHASE4CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 10, 2017

Conditions
Infertility
Interventions
DRUG

Progevera

DRUG

Orgalutran

Trial Locations (1)

Unknown

Clinica Eugin, Barcelona

All Listed Sponsors
lead

Fundació Privada Eugin

OTHER

NCT02796105 - Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors | Biotech Hunter | Biotech Hunter